Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection
Open Access
- 25 January 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 111 (6), 1833-1842
- https://doi.org/10.1016/j.xphs.2022.01.015
Abstract
No abstract availableFunding Information
- China International Medical Foundation (Z-2017-24-2028-03)
This publication has 45 references indexed in Scilit:
- Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and XposeCPT: Pharmacometrics & Systems Pharmacology, 2013
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects ModelsThe AAPS Journal, 2011
- Pharmacokinetic and Pharmacodynamic Properties of MeropenemClinical Infectious Diseases, 2008
- Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infectionsInternational Journal of Antimicrobial Agents, 2008
- MeropenemDrugs, 2008
- Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract InfectionsAntimicrobial Agents and Chemotherapy, 2007
- Neurotoxicity induced by beta-lactam antibiotics: from bench to bedsideEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'Nature Reviews Microbiology, 2004
- Meropenem Clinical PharmacokineticsClinical Pharmacokinetics, 1995
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976